| 摘要 |
The invention relates to the use of 2,5-dihydroxybenzenesulphonic acid in th e production of medicaments for the treatment of angiodependent diseases. More specifically, the invention relates to the use of the aforementioned compoun d and, in particular, the calcium and potassium salts thereof, for the treatme nt of two angiodependent diseases which present a reduction in apoptosis, namel y cancer and psoriasis. The invention also discloses the antiproliferative, antimigratory, antiangiogenic and proapoptotic capacity of said family of compounds in non-quiescent cells. In addition, the invention details the potentiating effect of said compounds on known cytostatic medicines in the treatment of tumours and, specifically, on gliomas. The invention further relates to the therapeutic efficacy of said compounds, based on the combined antiproliferative, antiangiogenic and proapoptotic capacities thereof, in th e treatment of chronic psoriatic plaques.
|
